Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gervais

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Therapie|March 10, 1999
[Acute voluntary poisoning with meprobamate may still be fatal: case report]H Peyrière, C Gervais, S Flangakis, et al.
Hybridoma|April 18, 2000
Development and characterization of a bispecific single-chain antibody directed against T cells and ovarian carcinomaJ Kriangkum, B Xu, C Gervais, et al.
Leukemia|October 22, 2004
A new translocation t(9;11)(q34;p15) fuses NUP98 to a novel homeobox partner gene, PRRX2, in a therapy-related acute myeloid leukemiaC Gervais, L Mauvieux, N Perrusson, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Targeted loss of heterozygosity in <i>Candida albicans</i> using CRISPR-Cas9Philippe C Després, Nicholas C Gervais, Meea Fogal, et al.
Antiviral Research|June 27, 2000
A novel high throughput screening assay for HCV NS3 helicase activityM Hicham Alaoui-Ismaili, C Gervais, S Brunette, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|November 1, 1983
[Treatment of human onchocerciasis with ivermectin]J P Coulaud, M Larivière, M C Gervais, et al.
Lancet (London, England)|September 1, 1984
Ivermectin in onchocerciasisJ P Coulaud, M Lariviere, M A Aziz, et al.
Genetics|August 12, 2025
Targeted loss of heterozygosity in Candida albicans using CRISPR-Cas9 reveals the functional impact of allelic variationPhilippe C Després, Nicholas C Gervais, Meea Fogal, et al.
Blood Cancer Journal|December 15, 2015
Four genetic lymphoma-specific events (MYC, BCL2, BCL6 and CCND1) identified in a high grade B lymphoma caseA Ittel, C Hélias, M P Wissler, et al.
Leukemia|October 9, 2012
A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasmC Gervais, L Dano, N Perrusson, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Therapie|March 10, 1999
[Acute voluntary poisoning with meprobamate may still be fatal: case report]H Peyrière, C Gervais, S Flangakis, et al.
Hybridoma|April 18, 2000
Development and characterization of a bispecific single-chain antibody directed against T cells and ovarian carcinomaJ Kriangkum, B Xu, C Gervais, et al.
Leukemia|October 22, 2004
A new translocation t(9;11)(q34;p15) fuses NUP98 to a novel homeobox partner gene, PRRX2, in a therapy-related acute myeloid leukemiaC Gervais, L Mauvieux, N Perrusson, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Targeted loss of heterozygosity in <i>Candida albicans</i> using CRISPR-Cas9Philippe C Després, Nicholas C Gervais, Meea Fogal, et al.
Antiviral Research|June 27, 2000
A novel high throughput screening assay for HCV NS3 helicase activityM Hicham Alaoui-Ismaili, C Gervais, S Brunette, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|November 1, 1983
[Treatment of human onchocerciasis with ivermectin]J P Coulaud, M Larivière, M C Gervais, et al.
Lancet (London, England)|September 1, 1984
Ivermectin in onchocerciasisJ P Coulaud, M Lariviere, M A Aziz, et al.
Genetics|August 12, 2025
Targeted loss of heterozygosity in Candida albicans using CRISPR-Cas9 reveals the functional impact of allelic variationPhilippe C Després, Nicholas C Gervais, Meea Fogal, et al.
Blood Cancer Journal|December 15, 2015
Four genetic lymphoma-specific events (MYC, BCL2, BCL6 and CCND1) identified in a high grade B lymphoma caseA Ittel, C Hélias, M P Wissler, et al.
Leukemia|October 9, 2012
A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasmC Gervais, L Dano, N Perrusson, et al.
Pageof 14